We have previously identified a gene in Staphylococcus aureus, agr, whose activity is required for high-level post-exponential-phase expression of a series of secreted proteins. In this paper, we describe the cloning of this gene in Escherichia coli by using an inserted transposon (TnSSI) as a cloning probe. The phase (5, 6). At the same time, the production of many proteins essential for growth and cell division is shut off. The regulation system that governs this changeover can be regarded as a metabolic toggle switch that is set at the end of exponential phase for accessory protein synthesis. When a new growth cycle is initiated (e.g., by dilution into fresh medium), the switch is reset for the synthesis of exponential-phase proteins. Neither the nature of the switch nor the identity of the metabolic factors involved is known. Pleiotropic mutations affecting the production of accessory proteins in S. aureus have been described by several groups (1, 10, 34), and it is likely that their analysis may be informative about this regulation system. Commonly, these mutations block post-exponentialphase synthesis of the following proteins: serine protease, nuclease, lipase, fibrinolysin, a-hemolysin, ,-hemolysin, 8-hemolysin, enterotoxin B, and toxic shock syndrome toxin-1 (TSST-1), whereas production of certain other exoproteins, including protein A and coagulase, is increased (1, 25 
In Staphylococcus aureus, as in most other bacteria, there is a class of accessory proteins, many of which are secreted, that are produced in laboratory cultures at the end of exponential growth and during the stationary phase (5, 6) . At the same time, the production of many proteins essential for growth and cell division is shut off. The regulation system that governs this changeover can be regarded as a metabolic toggle switch that is set at the end of exponential phase for accessory protein synthesis. When a new growth cycle is initiated (e.g., by dilution into fresh medium), the switch is reset for the synthesis of exponential-phase proteins. Neither the nature of the switch nor the identity of the metabolic factors involved is known. Pleiotropic mutations affecting the production of accessory proteins in S. aureus have been described by several groups (1, 10, 34) , and it is likely that their analysis may be informative about this regulation system. Commonly, these mutations block post-exponentialphase synthesis of the following proteins: serine protease, nuclease, lipase, fibrinolysin, a-hemolysin, ,-hemolysin, 8-hemolysin, enterotoxin B, and toxic shock syndrome toxin-1 (TSST-1), whereas production of certain other exoproteins, including protein A and coagulase, is increased (1, 25) . One such mutation is a transposon TnS51 insertion isolated by Mallonee et al. (12) and referred to as hla on the basis of its a-hemolysin-negative phenotype. Studies of the mutant strain revealed that its a-hemolysin structural gene is intact (22) and that its pleiotropic regulatory phenotype is correlated with a lack of mRNA corresponding to the genes whose expression is blocked (25; B. Kreiswirth and R. P. Novick, unpublished data). Consequently, with the concurrence of Pattee (P. A. Pattee, personal communication), we redesignated the gene agr (accessory gene regulator) (25) . We report here the cloning, initial characterization, and sequencing of the agr gene and show that the cloned gene restores the secretory protein phenotype of agr mutants and also of spontaneous exoprotein-deficient (Exp-) mutants.
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MATERIALS AND METHODS
Bacterial strains and plasmids. Table 1 contains the pedigrees of the staphylococcal strains used; Table 2 lists the plasmids. We have listed the pedigrees because we noticed retrospectively that certain of the 8325 derivatives in our stock collection that were used in these experiments are deficient in exoprotein production (Exp-), whereas others are proficient (Exp+). The (7) with the polylinker region of pUC18 inserted at its unique HindIlI site. RN4220 is a nitrosoguanidine-induced mutant of RN450 that is efficiently transformed with DNA from Escherichia coli (11) .
Media and growth conditions. CY broth (17) was used for liquid cultures, shaken at 37°C, and monitored turbidimetrically with a Klett-Summerson photoelectric colorimeter read at 540 nm. GL agar (17) was supplemented with antibiotics as indicated. Tetracycline (Tc), chloramphenicol (Cm), and erythromycin (Em) were used at 5 pug/ml.
Protoplast transformation was performed by the method of Chang and Cohen (2) as modified for S. aureus (20) . Transduction was with phage 80a as described (16 (30) with nick-translated (26) samples of gel-purified DNA as probes. Northern blot hybridization was performed by the procedure of Thomas (32) with whole-cell RNA purified by extraction with guanidinium isothiocyanate followed by centrifugation through a CsCl step gradient. Nick-translated samples of gel-purified DNA fragments were used as probes.
RESULTS
Cloning of agr. Strain RN4256 (11) was constructed in connection with an earlier study of TSST (11) by transforming a naturally occurring toxic shock strain, RN4282, for erythromycin resistance (Emr) with DNA from ISP546, the original Tn551-induced agr mutant isolated by Mallonee et al. (12) . A BglII fragment of plasmid pRN3174 containing one end of Tn551 (19) was used to probe a BglII digest of chromosomal DNA of RN4256 (25) for TnSS1 sequences. A single 4.7-kilobase (kb) fragment hybridized to the probe. DNA from the region of the gel containing this fragment was eluted and cloned to pBR322 in E. coli, and positive clones were identified by hybridization with the same probe. One such clone contained about 4 kb of chromosomal sequences flanking the inserted transposon. A ClaI fragment derived from this clone, containing the end of the transposon plus about 2.8 kb of the flanking DNA, was then used to probe a lambda library prepared from a partial SauIllIa digest of RN4282 chromosomal DNA. Positive plaques were purified by subculture and used to prepare lambda DNA for restriction analysis and for subcloning in pUC18. Restriction analysis of three clones (not shown) suggested that overlapping regions with different ends had been cloned. Initial subcloning of one of the X derivatives yielded a 4.0-kb EcoRI-PstI fragment that was used for further study. This fragment ( Fig. 1 ) was found to contain sequences homologous to the ClaI probe plus about 2.3 kb of DNA distal to the original TnS5J insertion site. To test the cloned fragment for agr activity, we ligated it to an appropriately digested sample (Fig. 1) . As shown in Fig. 2 , the largest agr+ fragment, Al, was present in both chromosomal and X clone digests (lanes 3 and 4), suggesting that contiguous DNA has been cloned and that there was no gross rearrangement during cloning. The difference in size between the BglII-EcoRI fragments shown in lanes 1 and 2 is due to the presence of an EcoRI site at the X insert junction. We therefore consider it unlikely that DNA rearrangements could account for the difference in agr activity between the native and cloned genes.
Subcloning. The agr determinant was mapped by subcloning. Various subfragments derived from the A2 fragment were inserted into the polylinker site of pSK265 and used to transform S. aureus RN4220. Additionally, to test for the possibility that the A2 clone did not contain the entire agr determinant, we cloned from the agr-containing lambda fragment a segment containing about 2.2 kb to the right of A2 but lacking about 1.6 kb to the left, as shown in Fig. 1 (clone Al). Although this fragment was successfully cloned to pUC18, we were unable to clone it in S. aureus, using the high-copy vector pSK265. For each subclone, the plasmid insert was verified by restriction analysis, and the derivative clone was transferred to various agr+ and agr host strains.
The resulting derivative strains were scored for production of a-and 1-hemolysins and TSST-1. The results of this subcloning are shown schematically in Fig. 1, and (1) . In RN4220, all of the agr+ clones strongly stimulated the expression of the two hemolysins-a to nearly the level shown by RN6390, and , to considerably higher levels-suggesting that the Exp-phenotype of RN4220 is due to a defect in agr expression. The agr defect in RN4220, however, is clearly different from that in ISP546. Thus, on the one hand, there was considerable residual expression of both hemolysins in RN4220 and both were stimulated about 10-fold by the cloned agr determinant in this strain. On the other hand, a-hemolysin was not detectably expressed in ISP546 and was stimulated at least 30-fold by agr, whereas ,B-hemolysin showed considerable activity in this agr strain but was stimulated only about 3-fold by the agr clones. Genotypic variability among ISP546, RN6390, and RN4220 is unlikely to be a major factor, as the three are coancestral; however, RN4220 has been through a nitrosoguanidine mutagenesis, which could have had significant genotypic consequences. It is also unlikely that variations in plasmid copy number or stability could be responsible, as the agr-bearing clones were stable in all three strains and had copy numbers that were indistinguishable from one another (although higher than that of the parental plasmid, pC194), about 90 copies per cell (data not shown).
Sequence analysis. We have determined the sequence of a 1.8-kb AccI fragment containing the site of the TnSSJ insertion inactivating agr, as shown in Fig. 1 (28). The sequenced region, indicated in Fig. 1, revealed two major open reading frames (ORFs) in the right-to-left direction, ORFi and ORF2, and a third, ORF3, in the other direction. ORF1, extending frompositions 1 to 714, included the TnSSl insertion site and was fully contained within fragment A17, the smallest agr+ fragment; it is therefore likely to represent agr. ORF2 began to the right of the sequenced region and ended at nucleotide position -38; ORF3 began to the left of the known sequence and ended at position 577, overlapping ORF1. The subcloning data are also consistent with the assignment of agr to ORFl: all subclones that contained this ORF were agr+, whereas all that interrupted it were agr defective. In Fig. 3 is shown the sequence of the ORF1 region, indicating the predicted amino acid sequence of the agr protein.
Gene fusion analysis. In a preliminary attempt to localize the agr promoter, we used a pair of promoter-probe vectors, pWN2018 and pWN2019, that we developed recently for gene fusion analysis (33) . These vectors contain the pUC18 polylinker in either orientation followed by a promoterless derivative of the S. aureus plasmid p1258 1-lactamase (bla) gene. In the absence of a cloned promoter, neither of these plasmids directs the synthesis of detectable ,-lactamase (33). The A8 fragment was chosen for this experiment because it includes 445 nucleotides (nt) 5' to the start of ORF-2 and terminates within the reading frame. The fragment was excised from pSK265 by double digestion with PstI and SstI and ligated to similarly digested preparations of each of the two vectors, and the resulting ligation mixtures were used to transform RN4220 protoplasts, with selection for the Cmr marker of the vector. Note that this strategy should produce derivatives of pWN2019 with the agr insert oriented in the same direction as the bla determinant of the vector and derivatives of pWN2018 with the insert in the VOL. 170, 1988 opposite orientation. Restriction analysis of plasmids recovered from the transformants confirmed the expected orientations, and one of each type was transferred to RN6390, RN4220, and ISP546 and analyzed for ,-lactamase production in exponential-and post-exponential-phase cultures. A pWN2018 derivative (insert oriented opposite to the bla gene) produced no detectable P-lactamase, whereas a pWN2019 derivative (insert oriented in the same direction as bla) produced about 1 U of enzyme per mg (dry weight) of cells in all three strains. These activities were rather low, about 0.05% of that seen with a constitutive mutation of the native ,B-lactamase expression system (20) , were unaffected by the presence of an active agr determinant, and showed no change during the transition from exponential to post-exponential phase.
agr transcription. In Fig. 4 is shown the autoradiogram of a Northern (RNA) blot hybridization analysis of whole-cell RNA probed with the agr-specific fragment A6. RNA was prepared from both exponential-and post-exponential-phase cells and from the agr+ and agr-defective strains RN6390 and ISP546, respectively. As shown in the autoradiogram, the TnSSJ insertion in agr blocked detectable transcription of the agr region. It is assumed that the promoter identified by the bla fusions is too weak to have been picked up in this blot. Additionally, this rather preliminary experiment suggests that agr is transcribed more actively in post-exponential-than in exponential-phase cells; there is, moreover, the hint of several agr-specific bands, at least one of which is present in the post-exponential-phase preparation but absent from the exponential-phase cells. From the positions of other transcripts in parallel gels (not shown), the largest species is estimated to be about 3 to 4 kb in length.
DISCUSSION
The data presented in this report demonstrate that agr is a trans-activator of a series of exoprotein genes that are expressed during the post-exponential phase of growth in S. aureus. The cloned agr determinant encodes a potential polypeptide of 241 amino acid residues, and the results of subcloning suggest that the agr product is, in fact, this polypeptide. This conclusion is strengthened by the demonstration of a polypeptide of the predicted size following cloning of fragment A16 to a Gemini vector under control of the T7 promoter and overexpression in E. coli following the induction of T7 polymerase (31; unpublished data). Earlier studies (25) have suggested that agr acts at the level of transcription. agr itself, however, does not appear to be involved directly in the temporal aspect of the regulation, as the residual activity of agr-sensitive genes is still temporally regulated in agr mutants (8, 25) . An important question is that of the regulation of agr itself. On the one hand, we have identified, by means of gene fusion analysis, an agr promoter that is probably located less than 100 nt 5' to the agr start. This promoter is rather weak and has about the same activity in agr+ and agr-defective host strains and the same activity in post-exponential-phase as in exponentially growing cells. On the other hand, Northern blotting with an agr probe revealed strong transcriptional activity that was absent in agr-defective strains, showed considerable growth phase dependency, and was initiated about 2 kb upstream. Morfeldt and co-workers, who have independently cloned agr (14) , have identified a strong leftward promoter, just to the right of the PstI site (Fig. 1) , that directs the synthesis of a 3.5-kb agr transcript. This transcript was similarly absent from agr mutants and is likely to correspond to the major . A 10-,ug portion of each sample was heat-denatured and electrophoresed on 1.5% agarose containing 20 mM morpholinopropanesulfonic acid, pH 7.0, 2.2 M formaldehyde, and ethidium bromide (1 i.g/ml). RNA was transferred to a Nytran filter (Schleicher & Schuell) by using the Janssen semidry electroblotter, and the filter was prehybridized and hybridized at 65°C and then probed with a 582-bp DdeI-BstEII fragment that is contained within agr subclone pRN6585 (Streptococcus epidermidis, Fig. 1 ). Lanes 1E and 1L and 2E and 2L correspond to early-and late-phase cell cultures, respectively, from ISP546 (agr mutant) and RN6390 (agr+), respectively. Probes were labeled with 32P by nick translation (12) . Early (E) refers to mid-exponential-phase RN6390 cells that are not expressing a-hemolysin; late (L) refers to earlystationary-phase cells that are expressing a-hemolysin maximally. transcript shown in Fig. 4 . Together, these results suggest that there are at least two agr promoters, a strong one to the right of the PstI site and a weak one on the A8 fragment, close to the start of the gene. The absence of the large transcript in agr mutant strains suggests the possibility that a functional agr product is required for the activation of the upstream promoter. This would mean that agr is part of an operon that has both growth-phase-dependent and -independent components and that includes ORF2 and possibly other products as well.
Measurements of three agr-regulated exoproteins with various agr+ subclones, in various host strains, revealed a complex pattern of expression that will probably be inter- For example, there seem to be three distinct levels of expression for a-hemolysin in the three strains ISP546 (agr), RN4220 (agr mutant), and RN6390 (agr+), but only two levels for,3-hemolysin. These results suggest that there may be two distinct agr activities; at unit dosage, ,-hemolysin would require only one of these for expression at the wild-type level, whereas a-hemolysin would require both. These activities could be correlated with the two different promoters thus far identified-the weak one just 5' to ORF1 and the much stronger one upstream-and it seems probable that ORF2 may also be involved. Results with the cloned fragments also suggest a difference between a-hemolysin and ,-hemolysin regulation in that ,-hemolysin expression was stimulated to the same extent by all of the agr+ clones, whereas a-hemolysin, and also TSST-1, showed three more or less distinct levels correlated with removal of sequences 5' to agr. Our present view is that the variability in expression is likely to be a combination of gene dosage effects plus subtle consequences of genome organization that will be revealed only by further study. With respect to other regulatory systems, agr could be a member of the class of recently characterized cytoplasmic transcriptional activators (24) . However, computer searches have thus far failed to reveal any significant amino acid sequence similarity between the predicted agr polypeptide and these activators, Bacillus subtilis sigma factors, or other proteins in the Dayhoff data base. More extensive computer analyses are currently in progress.
